Asia represents a huge opportunity for business expansion however, important risks must also be considered, writes Cèlia Zwahlen.
A third level qualification in science can be a steppingstone to diverse career paths. We examine the experiences of two biotechnology graduates.
The academic and commercial worlds have traditionally remained apart. By investing in collaboration can we bridge the divide and release the commercial potential to create a true knowledge economy?
In recent years Élan has been on a roller coaster ride, during which shares have fallen and risen with the fortunes of the drug giant's leading product, Tysabri, a treatment for MS. What does the future hold for the Irish biotech company?
Seamus McGardle explores the potential of the children of the baby boomers and suggests that this generation should be supported and allowed to create a new Celtic Tiger or even faster cat.
Ireland's Chief Scientific Advisor aims to shape the development of science and technology in Ireland to ensure Ireland's future economic success. Anna Clarke speaks to Professor Patrick Cunningham.
In the first media interview since his appointment as the CEO designate of IDA, Barry O'Leary talks to Constantin Gurdgiev about the future direction for Ireland, Inc and the role of IDA in driving new FDI in the key traded sectors of our economy.
Baxter Healthcare SA, based in Castlebar, was recently recognised for its innovation in re-launching a €15m product that in 2004 had been removed from the market. Louise Hodgson speaks to project leader John Doherty.
Constantin Gurdiev explores conventional and emerging theories regarding innovation and discusses the implications for Ireland's knowledge economy.
In order to ensure that the true potential of nanotechnologies are realized we must understand and legislate for the associated risks. Andrew D. Maynard discusses.
By encouraging local managers to up-skill and become globally aware Ireland will create a new breed of leaders who manage and implement change, writes Seamus McGardle, Director-Group, Science Recruitment Ireland.
Nanotechnology is the buzz word that suggests mind-bending science and fascinating new developments. Anna Clarke speaks to Professor Marek Radomski, Chair of Pharmacology, Trinity College Dublin and of CRANN.
To achieve the capacity of competing regions Northern Ireland's life sciences sector must focus on strategic development of priority research and business areas.
In recent years National University of Ireland, Galway has invested to establish itself as a research intensive organisation. The university's Technology Transfer Office has increased the number of patent applications and commercialisable products to come out of the university.
Will Ireland's pharmachem sector be forced to choose between pursuing a strategy focused upon the retention of manufacturing operations or one that promotes research and innovation? Or is there a third way? Célia Zwahlen reports.